NovoCure Statistics Share Statistics NovoCure has 111.8M
shares outstanding. The number of shares has increased by 3.02%
in one year.
Shares Outstanding 111.8M Shares Change (YoY) 3.02% Shares Change (QoQ) 1.43% Owned by Institutions (%) 86.34% Shares Floating 98.9M Failed to Deliver (FTD) Shares 25 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 5.51M, so 4.93% of the outstanding
shares have been sold short.
Short Interest 5.51M Short % of Shares Out 4.93% Short % of Float 7.79% Short Ratio (days to cover) 2.94
Valuation Ratios The PE ratio is -19.06 and the forward
PE ratio is -7.27.
NovoCure's PEG ratio is
0.95.
PE Ratio -19.06 Forward PE -7.27 PS Ratio 5.31 Forward PS 2 PB Ratio 8.92 P/FCF Ratio -46.42 PEG Ratio 0.95
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NovoCure.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.46,
with a Debt / Equity ratio of 1.9.
Current Ratio 1.46 Quick Ratio 1.42 Debt / Equity 1.9 Debt / EBITDA -6.31 Debt / FCF -9.87 Interest Coverage -14.62
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $406.73K Profits Per Employee $-113.32K Employee Count 1,488 Asset Turnover 0.49 Inventory Turnover 3.91
Taxes Income Tax 37.47M Effective Tax Rate -28.56%
Stock Price Statistics The stock price has increased by -34.57% in the
last 52 weeks. The beta is 0.58, so NovoCure's
price volatility has been higher than the market average.
Beta 0.58 52-Week Price Change -34.57% 50-Day Moving Average 13.42 200-Day Moving Average 19.4 Relative Strength Index (RSI) 53.54 Average Volume (20 Days) 1,604,711
Income Statement In the last 12 months, NovoCure had revenue of 605.22M
and earned -168.63M
in profits. Earnings per share was -1.56.
Revenue 605.22M Gross Profit 468.04M Operating Income -170.5M Net Income -168.63M EBITDA -108.26M EBIT -120.82M Earnings Per Share (EPS) -1.56
Full Income Statement Balance Sheet The company has 163.77M in cash and 683.35M in
debt, giving a net cash position of -519.59M.
Cash & Cash Equivalents 163.77M Total Debt 683.35M Net Cash -519.59M Retained Earnings -1.15B Total Assets 1.25B Working Capital 333.67M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -26.37M
and capital expenditures -42.85M, giving a free cash flow of -69.22M.
Operating Cash Flow -26.37M Capital Expenditures -42.85M Free Cash Flow -69.22M FCF Per Share -0.64
Full Cash Flow Statement Margins Gross margin is 77.33%, with operating and profit margins of -28.17% and -27.86%.
Gross Margin 77.33% Operating Margin -28.17% Pretax Margin -21.67% Profit Margin -27.86% EBITDA Margin -17.89% EBIT Margin -28.17% FCF Margin -11.44%
